[1]文学,孙红,王洪,等.PTHrP类似物阿巴洛肽在骨质疏松症中的研究进展[J].中华老年骨科与康复电子杂志,2021,(02):117-121.[doi:10.3877/cma.j.issn.2096-0263.2021.02.009]
 Wen Xue,Sun Hong,Wang Hong,et al.Research progress of PTHrP analogue abaloparide in osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2021,(02):117-121.[doi:10.3877/cma.j.issn.2096-0263.2021.02.009]
点击复制

PTHrP类似物阿巴洛肽在骨质疏松症中的研究进展()
分享到:

中华老年骨科与康复电子杂志[ISSN:1674-3911/CN:11-9292/R]

卷:
期数:
2021年02
页码:
117-121
栏目:
综述
出版日期:
2021-04-05

文章信息/Info

Title:
Research progress of PTHrP analogue abaloparide in osteoporosis
作者:
文学1孙红2王洪2刘淼2宁旭2
550004 贵阳,贵州医科大学1;550004 贵阳,贵州医科大学附属医院骨科2
Author(s):
Wen Xue1 Sun Hong2 Wang Hong2 Liu Miao2 Ning Xu2.
1Guizhou Medical University, Guiyang 550004, China; 2Department of Orthopaedics, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China
关键词:
骨质疏松症 PTHrP类似物 阿巴洛肽 特立帕肽 综述文献
Keywords:
Osteoporosis PTHrP analog Abaloparatide Teriparatide Literature review
DOI:
10.3877/cma.j.issn.2096-0263.2021.02.009
文献标志码:
A
摘要:
阿巴洛肽是人类甲状旁腺激素相关蛋白(PTHrP)的氨基酸合成类似物,是一种新型的甲状旁腺激素1受体信号通路的选择性激活剂,可增加骨密度和骨量,改善骨微结构和强度,是继特立帕肽后第二种骨合成药物。PTHrP类似物可通过提高骨量,促进骨合成。许多临床前研究及基础研究发现阿巴洛肽对于治疗绝经后骨质疏松疗效确切,为治疗绝经后骨质疏松症提供了新的治疗策略,但仍需大量及大型动物研究以更好的验证PTHrP类似物用于治疗骨质疏松症的生物安全性。本文就骨合成药物PTHrP类似物阿巴洛肽在骨质疏松症患者的研究进展作一综述。
Abstract:
Abaloparatide, the amino acid synthesis analogue of human parathyroid hormone-related protein (PTHrP), is a novel selective activator of the parathyroid hormone-1 receptor signaling pathway, which can increase bone density and bone mass, improve bone microstructure and strength, and is the second bone synthesis drug after Teriptide.Many preclinical and basic studies have found that abaloparatide is effective in the treatment of postmenopausal osteoporosis, providing a new treatment strategy for postmenopausal osteoporosis, but a large number of studies and large animal studies are still needed to better verify the biosafsafety of PTHrP analogue in the treatment of osteoporosis. This article reviews the progress in the study of the bone synthesis drug PTHrP analogue abaloparatide in patients with osteoporosis.

相似文献/References:

[1]马晓龙,刘强,吴斗,等.骨质疏松显微骨折早期发生发展过程的实验研究[J].中华老年骨科与康复电子杂志,2016,(03):129.[doi:10.3877/cma.j.issn.2096-0263.2016.03.001]
 Ma Xiaolong,Liu Qiang,Wu Dou,et al.Experimental study of osteoporotic microsurgery fractures in the early development process[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(02):129.[doi:10.3877/cma.j.issn.2096-0263.2016.03.001]
[2]崔红旺,蒋电明.骨细胞程序性死亡在骨质疏松中作用的研究进展[J].中华老年骨科与康复电子杂志,2016,(03):181.[doi:10.3877/cma.j.issn.2096-0263.2016.03.011]
 Cui Hongwang,Jiang Dianming.Effect of the programmed cell death of osteocyte on osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(02):181.[doi:10.3877/cma.j.issn.2096-0263.2016.03.011]
[3]李子怡,李玉坤.OPG/RANK/RANKL信号通路在骨质疏松症中的研究进展和应用[J].中华老年骨科与康复电子杂志,2017,(02):124.[doi:10.3877/cma.j.issn.2096-0263.2017.02.012]
 Li Ziyi,Li Yukun.Researching progress and application of OPG-RANK-RANKL signaling pathway in osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(02):124.[doi:10.3877/cma.j.issn.2096-0263.2017.02.012]
[4]雷涛,申勇.老年骨质疏松性椎体骨折若干问题的探讨[J].中华老年骨科与康复电子杂志,2017,(04):248.[doi:10.3877/cma.j.issn.2096-0263.2017.04.010]
 Lei Tao,Shen Yong..A brief discussion of osteoporotic vertebral fractures in elderly patients[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(02):248.[doi:10.3877/cma.j.issn.2096-0263.2017.04.010]
[5]马树伟.球囊扩张椎体成形术治疗急性与亚急性期骨质疏松椎体压缩骨折的疗效对比[J].中华老年骨科与康复电子杂志,2017,(06):341.[doi:10.3877/cma.j.issn.2096-0263.2017.06.005]
 Ma Shuwei.Clinical efficacy of percutaneous kyphoplasty in the treatment of acute and subacute phase of osteoporotic vertebral compression fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(02):341.[doi:10.3877/cma.j.issn.2096-0263.2017.06.005]
[6]刘伟,傅光涛,胡旭民,等.唑来膦酸治疗绝经后骨质疏松发生脆性骨折的临床研究[J].中华老年骨科与康复电子杂志,2017,(06):351.[doi:10.3877/cma.j.issn.2096-0263.2017.06.007]
 Liu Wei,Fu Guangtao,Hu Xumin,et al.Analysis in postmenopausal osteoporosis patients with fragility fracture during zoledronic acid treatment[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(02):351.[doi:10.3877/cma.j.issn.2096-0263.2017.06.007]
[7]邢浩,刘强,吴斗,等.双膦酸盐治疗股骨非典型性骨折的研究进展[J].中华老年骨科与康复电子杂志,2018,(02):118.[doi:10.3877/cma.j.issn.2096-0263.2018.02.010]
 Bisphosphonates and atypical femur fractures femur[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(02):118.[doi:10.3877/cma.j.issn.2096-0263.2018.02.010]
[8]梁伟,吴斗,赵恩哲,等.皮质厚度在骨质疏松性髋部骨折中的应用研究[J].中华老年骨科与康复电子杂志,2018,(03):184.[doi:10.3877/cma.j.issn.2096-0263.2018.03.012]
 Liang Wei,Wu Dou,Zhao Enzhe,et al.Application research of Cortical thickness in osteoporotic hip fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(02):184.[doi:10.3877/cma.j.issn.2096-0263.2018.03.012]
[9]谢亚明,谢国盛,林蒙,等.网袋成形术与椎体后凸成形术治疗骨质疏松性椎体压缩骨折的早期疗效比较[J].中华老年骨科与康复电子杂志,2018,(04):202.[doi:10.3877/cma.j.issn.2096-0263.2018.04.003]
 Xie Yaming,Xie Guosheng,Lin Meng,et al.Early clinical outcome of vesselplasty and kyphoplasty in treatment of osteoporotic vertebral compression fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(02):202.[doi:10.3877/cma.j.issn.2096-0263.2018.04.003]
[10]吴石磊 刘勇 邵增务 田青. 骨组织细胞外泌体对骨代谢作用的研究现状[J].中华老年骨科与康复电子杂志,2018,(05):308.
 Wu Shilei,Liu Yong,Shao Zengwu,et al. Research status of bone tissue-derived exosomes on bone metabolism[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(02):308.

备注/Memo

备注/Memo:
基金项目:贵州省卫生健康委科学技术基金项目(gzwjkj2019-1-134;gzwjkj2020-1-120)
更新日期/Last Update: 2021-05-10